Cargando…
Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: a meta-analysis
PURPOSE: Glutaric aciduria type 1 (GA1), a rare inherited neurometabolic disorder, results in a complex movement disorder (MD) with predominant dystonia if untreated. Implementation into newborn screening (NBS) programs and adherence to recommended therapy are thought to improve the neurological out...
Autores principales: | Boy, Nikolas, Mengler, Katharina, Heringer-Seifert, Jana, Hoffmann, Georg F., Garbade, Sven F., Kölker, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790745/ https://www.ncbi.nlm.nih.gov/pubmed/32981931 http://dx.doi.org/10.1038/s41436-020-00971-4 |
Ejemplares similares
-
A cross-sectional controlled developmental study of neuropsychological functions in patients with glutaric aciduria type I
por: Boy, Nikolas, et al.
Publicado: (2015) -
Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity
por: Boy, Nikolas, et al.
Publicado: (2017) -
Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis
por: Pfeil, Johannes, et al.
Publicado: (2013) -
Machine Learning Methods Improve Specificity in Newborn Screening for Isovaleric Aciduria
por: Zaunseder, Elaine, et al.
Publicado: (2023) -
The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study
por: Märtner, E. M. Charlotte, et al.
Publicado: (2021)